Logo image of BN

BROOKFIELD CORP (BN) Stock Fundamental Analysis

NYSE:BN - New York Stock Exchange, Inc. - CA11271J1075 - Common Stock - Currency: USD

53.25  +0.33 (+0.62%)

After market: 53.25 0 (0%)

Fundamental Rating

3

Taking everything into account, BN scores 3 out of 10 in our fundamental rating. BN was compared to 227 industry peers in the Capital Markets industry. Both the profitability and financial health of BN have multiple concerns. BN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BN was profitable.
BN had a positive operating cash flow in the past year.
BN had positive earnings in 4 of the past 5 years.
BN had a positive operating cash flow in 4 of the past 5 years.
BN Yearly Net Income VS EBIT VS OCF VS FCFBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

BN has a Return On Assets of 0.15%. This is in the lower half of the industry: BN underperforms 74.89% of its industry peers.
BN's Return On Equity of 1.59% is on the low side compared to the rest of the industry. BN is outperformed by 73.13% of its industry peers.
BN has a Return On Invested Capital (3.72%) which is in line with its industry peers.
BN had an Average Return On Invested Capital over the past 3 years of 3.59%. This is below the industry average of 7.09%.
The last Return On Invested Capital (3.72%) for BN is above the 3 year average (3.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.15%
ROE 1.59%
ROIC 3.72%
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.59%
ROIC(5y)3.39%
BN Yearly ROA, ROE, ROICBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

BN has a Profit Margin of 0.81%. This is in the lower half of the industry: BN underperforms 74.01% of its industry peers.
BN's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 24.52%, BN is in line with its industry, outperforming 44.93% of the companies in the same industry.
BN's Operating Margin has improved in the last couple of years.
BN has a Gross Margin of 18.62%. This is in the lower half of the industry: BN underperforms 68.72% of its industry peers.
BN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 24.52%
PM (TTM) 0.81%
GM 18.62%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y-8.13%
GM growth 5Y-3.62%
BN Yearly Profit, Operating, Gross MarginsBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

0

2. Health

2.1 Basic Checks

The number of shares outstanding for BN has been increased compared to 1 year ago.
BN has more shares outstanding than it did 5 years ago.
BN has a better debt/assets ratio than last year.
BN Yearly Shares OutstandingBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BN Yearly Total Debt VS Total AssetsBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

Based on the Altman-Z score of 0.47, we must say that BN is in the distress zone and has some risk of bankruptcy.
BN has a Altman-Z score of 0.47. This is in the lower half of the industry: BN underperforms 64.76% of its industry peers.
A Debt/Equity ratio of 5.26 is on the high side and indicates that BN has dependencies on debt financing.
BN's Debt to Equity ratio of 5.26 is on the low side compared to the rest of the industry. BN is outperformed by 83.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.26
Debt/FCF N/A
Altman-Z 0.47
ROIC/WACCN/A
WACCN/A
BN Yearly LT Debt VS Equity VS FCFBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B 200B

2.3 Liquidity

BN has a Current Ratio of 0.84. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
BN has a worse Current ratio (0.84) than 62.11% of its industry peers.
BN has a Quick Ratio of 0.84. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
BN's Quick ratio of 0.66 is on the low side compared to the rest of the industry. BN is outperformed by 68.28% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.66
BN Yearly Current Assets VS Current LiabilitesBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

6

3. Growth

3.1 Past

BN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.02%, which is quite impressive.
The Earnings Per Share has been growing by 18.12% on average over the past years. This is quite good.
Looking at the last year, BN shows a very negative growth in Revenue. The Revenue has decreased by -10.34% in the last year.
Measured over the past years, BN shows a small growth in Revenue. The Revenue has been growing by 4.86% on average per year.
EPS 1Y (TTM)31.02%
EPS 3Y-50.15%
EPS 5Y18.12%
EPS Q2Q%21.69%
Revenue 1Y (TTM)-10.34%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%-20.77%

3.2 Future

Based on estimates for the next years, BN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.72% on average per year.
The Revenue is expected to grow by 20.21% on average over the next years. This is a very strong growth
EPS Next Y-0.27%
EPS Next 2Y9.91%
EPS Next 3Y14.72%
EPS Next 5YN/A
Revenue Next Year24.4%
Revenue Next 2Y19.64%
Revenue Next 3Y20.21%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BN Yearly Revenue VS EstimatesBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
BN Yearly EPS VS EstimatesBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.41, the valuation of BN can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of BN is on the same level as its industry peers.
BN is valuated cheaply when we compare the Price/Earnings ratio to 28.92, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.45, the valuation of BN can be described as correct.
BN's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.65. BN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.41
Fwd PE 13.45
BN Price Earnings VS Forward Price EarningsBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BN is valued cheaper than 86.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.05
BN Per share dataBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

BN's earnings are expected to grow with 14.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.74
EPS Next 2Y9.91%
EPS Next 3Y14.72%

1

5. Dividend

5.1 Amount

BN has a yearly dividend return of 0.74%, which is pretty low.
Compared to an average industry Dividend Yield of 8.41, BN is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.51, BN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.74%

5.2 History

The dividend of BN decreases each year by -5.12%.
BN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BN decreased recently.
Dividend Growth(5Y)-5.12%
Div Incr Years1
Div Non Decr Years1
BN Yearly Dividends per shareBN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

87.94% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
DP87.94%
EPS Next 2Y9.91%
EPS Next 3Y14.72%
BN Yearly Income VS Free CF VS DividendBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B
BN Dividend Payout.BN Dividend Payout, showing the Payout Ratio.BN Dividend Payout.PayoutRetained Earnings

BROOKFIELD CORP

NYSE:BN (4/25/2025, 4:15:01 PM)

After market: 53.25 0 (0%)

53.25

+0.33 (+0.62%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners56.84%
Inst Owner Change-0.01%
Ins Owners10.91%
Ins Owner ChangeN/A
Market Cap87.69B
Analysts76.67
Price Target69.51 (30.54%)
Short Float %0.87%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield 0.74%
Yearly Dividend0.39
Dividend Growth(5Y)-5.12%
DP87.94%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-14 2025-03-14 (0.09)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.18%
Min EPS beat(2)-0.3%
Max EPS beat(2)68.65%
EPS beat(4)3
Avg EPS beat(4)20.85%
Min EPS beat(4)-0.3%
Max EPS beat(4)68.65%
EPS beat(8)6
Avg EPS beat(8)-3.67%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1592.59%
Min Revenue beat(2)1473.07%
Max Revenue beat(2)1712.11%
Revenue beat(4)4
Avg Revenue beat(4)798.76%
Min Revenue beat(4)0.84%
Max Revenue beat(4)1712.11%
Revenue beat(8)8
Avg Revenue beat(8)413.33%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.16%
EPS NQ rev (1m)-1.68%
EPS NQ rev (3m)-1.96%
EPS NY rev (1m)-0.72%
EPS NY rev (3m)-2.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.22%
Valuation
Industry RankSector Rank
PE 13.41
Fwd PE 13.45
P/S 0.96
P/FCF N/A
P/OCF 15.13
P/B 1.89
P/tB N/A
EV/EBITDA 10.05
EPS(TTM)3.97
EY7.46%
EPS(NY)3.96
Fwd EY7.44%
FCF(TTM)-8.5
FCFYN/A
OCF(TTM)3.52
OCFY6.61%
SpS55.32
BVpS28.22
TBVpS-15.64
PEG (NY)N/A
PEG (5Y)0.74
Profitability
Industry RankSector Rank
ROA 0.15%
ROE 1.59%
ROCE 5%
ROIC 3.72%
ROICexc 3.82%
ROICexgc 4.58%
OM 24.52%
PM (TTM) 0.81%
GM 18.62%
FCFM N/A
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.59%
ROIC(5y)3.39%
ROICexc(3y)3.72%
ROICexc(5y)3.52%
ROICexgc(3y)4.6%
ROICexgc(5y)4.29%
ROCE(3y)4.82%
ROCE(5y)4.56%
ROICexcg growth 3Y-1.35%
ROICexcg growth 5Y2.42%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y-8.13%
GM growth 5Y-3.62%
F-Score7
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 5.26
Debt/FCF N/A
Debt/EBITDA 7.62
Cap/Depr 203.03%
Cap/Sales 21.72%
Interest Coverage 250
Cash Conversion 18.06%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.66
Altman-Z 0.47
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.02%
EPS 3Y-50.15%
EPS 5Y18.12%
EPS Q2Q%21.69%
EPS Next Y-0.27%
EPS Next 2Y9.91%
EPS Next 3Y14.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.34%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%-20.77%
Revenue Next Year24.4%
Revenue Next 2Y19.64%
Revenue Next 3Y20.21%
Revenue Next 5YN/A
EBIT growth 1Y25.89%
EBIT growth 3Y9.35%
EBIT growth 5Y11.02%
EBIT Next Year302.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.97%
OCF growth 3YN/A
OCF growth 5YN/A